| Anti‐vascular endothelial growth factor for diabetic macular oedema: A network meta‐analysis | 2023 | Cochrane Database of Systematic Reviews |
| Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. | 2023 | Cochrane Database of Systematic Reviews |
| Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis. | 2023 | Advances in Therapy |
| Efficacy and safety of anti-vascular endothelial growth agents for the treatment of polypoidal choroidal vasculopathy: A systematic review and meta-analysis. | 2023 | Survey of Ophthalmology |
| Efficacy and safety of brolucizumab, aflibercept, and ranibizumab for the treatment of patients with visual impairment due to diabetic macular oedema: A systematic review and network meta-analysis. | 2023 | Diabetes Therapy |
| Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: A meta-analysis. | 2023 | Frontiers in Endocrinology |
| Treat and extend regimen for diabetic macular oedema - a systematic review and meta-analysis. | 2023 | Graefe's Archive for Clinical and Experimental Ophthalmology |
| The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: A systematic review and meta-analysis. | 2023 | Italian Journal of Pediatrics |
| Determining the Superiority of Vitrectomy vs Aflibercept for Treating Dense Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. | 2023 | Clinical Ophtalmology |
| Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: A meta-analysis of trials. | 2023 | Eye |
| Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: A systematic review and network meta-analysis | 2023 | BMC Ophthalmology |
| Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis. | 2023 | Biomolecules & Biomedicine |
| Comparison of adverse events between intravitreal anti VEGF and laser photocoagulation for treatment requiring retinopathy of prematurity: A systematic review. | 2023 | International Ophthalmology |
| Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: A systematic review and meta-analysis. | 2023 | Eye |
| Effect of anti-VEGF therapy on the disease progression of neovascular age-related macular degeneration: A systematic review and model-based meta-analysis. | 2022 | The Journal of Clinical Pharmacology |
| Comparative effectiveness of intravitreal anti-vascular endothelial growth factor therapies for managing neovascular age-related macular degeneration: A meta-analysis. | 2022 | Journal of Clinical Medicine |
| The 12- and 24-month effects of intravitreal ranibizumab, aflibercept, and bevacizumab on intraocular pressure: A network meta-analysis. | 2022 | Ophthalmology |
| Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: A meta-analysis and systematic review. | 2022 | International Journal of Ophthalmology |
| Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis. | 2022 | Journal of Current Ophthalmology |
| Comparative efficacy of brolucizumab in the treatment of neovascular age-related macular degeneration: A systematic literature review and network meta-analysis. | 2022 | Advances in Therapy |
| Real-World Evidence in the Management of Diabetic Macular Edema with Intravitreal Anti-VEGFs in Asia: A Systematic Literature Review. | 2022 | Clinical Ophthalmology |
| Pro re nata versus fixed aflibercept regimen for neovascular age-related macular degeneration: A systematic review and meta-analysis. | 2022 | International Journal of Retina and Vitreous |
| Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis. | 2022 | Frontiers in Pharmacology |
| Association Between Visual Acuity and Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. | 2022 | JAMA Ophtalmology |
| Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic Review. | 2022 | Current Pharmaceutical Design |
| Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression. | 2022 | Journal of Clinical medicine |
| Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review. | 2022 | Journal of Vitreoretinal Diseases |
| Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review. | 2022 | Survey of Ophthalmology |
| Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis. | 2022 | Ophthalmologica |
| Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies. | 2022 | Acta Ophthalmologica |
| A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity. | 2022 | Ophthalmology |
| The Efficacy and Safety of Brolucizumab for the Treatment of nAMD: A Systematic Review and Meta-Analysis. | 2022 | Frontiers in Pharmacology |
| Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. | 2022 | Frontiers in Medicine |
| Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes. | 2022 | Survey of Ophthalmology |
| Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis. | 2021 | Graefe's Archive for Clinical and Experimental Ophthalmology |
| Efficacy and safety of anti–vascular endothelial growth factor monotherapies for neovascular age-related macular degeneration: A mixed treatment comparison. | 2021 | Frontiers in Pharmacology |
| Anti-vascular endothelial growth factor therapy for age-related macular degeneration: A systematic review and network meta-analysis. | 2021 | Systematic Reviews |
| Managing diabetic macular edema in clinical practice: Systematic review and meta-analysis of current strategies and treatment options. | 2021 | Clinical Ophthalmology |
| Aflibercept for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. | 2021 | Ophthalmic Surgery, Lasers and Imaging Retina |
| Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society. | 2021 | Asia-Pacific journal of Ophthalmology |
| Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options. | 2021 | Clinical Ophthalmology |
| Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: A systematic review and network meta-analysis. | 2021 | Acta Ophtamologica |
| Antivascular Endothelial Growth Factor Dosing And Expected Acuity Outcome At 1 Year. | 2021 | Retina |
| How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview. | 2020 | Advances in Therapy |
| Efficacy of switching therapy to aflibercept for patients with persistent diabetic macular edema: A systematic review and meta-analysis. | 2020 | Annals of Translational Medicine |
| Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (AMD): A systematic review and network meta-analysis of direct comparative studies. | 2020 | Journal of Clinical Medicine |
| Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: Systematic review and Bayesian network meta-analysis. | 2020 | Therapeutic Advances in Chronic Disease |
| Efficacy of conversion to aflibercept for diabetic macular edema previously refractory to bevacizumab or ranibizumab: A meta-analysis of high-quality nonrandomized studies. | 2020 | The Annals of Pharmacotherapy |
| Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. | 2020 | The Cochrane Database of Systematic Reviews |
| Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. | 2020 | The Cochrane Database of Systematic Reviews |
| Efficacy and treatment burden of intravitreal aflibercept versus intravitreal ranibizumab treat-and-extend regimens at 2 years: Network meta-analysis incorporating individual patient data meta-regression and matching-adjusted indirect comparison. | 2019 | Advances in Therapy |
| A meta‐analysis of patients with treatment‐resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept. | 2019 | Acta Ophthalmologica |
| One year effectiveness study of intravitreal aflibercept in neovascular age-related macular degeneration: A meta-analysis. | 2019 | Acta Ophthalmologica |
| Anti-vascular endothelial growth factor treatment for retinal conditions: A systematic review and meta-analysis. | 2019 | BMJ Open |
| Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: A systematic review and meta-analysis. | 2019 | The British Journal of Ophthalmology |
| Aflibercept versus dexamethasone for macular edema secondary to central retinal vein occlusion. | 2019 | Medwave |
| Intravitreal Medications for Retinal Vein Occlusion: Systematic Review and Meta-analysis. | 2019 | Journal of Ophthalmic & Vision Research |
| Current Outcomes of Anti-VEGF Therapy in the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusions: A Meta-Analysis. | 2019 | Ophtalmologica |
